BC Platforms has signed a partnership with Dartmouth-Hitchcock Medical Center’s laboratory of Clinical Genomics and Advanced Technology in the Department of Pathology & Laboratory Medicine in the US, focused on providing data management solutions in cancer research.
BC Platforms will link clinical and genomic data from Dartmouth-Hitchcock’s tumour biobank to enable rapid statistical analysis of the patient population via the BC|GENOME toolset. BC Platforms will also provide Dartmouth-Hitchcock with BC|PREDICT to facilitate the rapid elucidation of disease related genes from next generation sequencing data. The goal of the partnership is to provide valuable information for translational research to transform the way that cancer is being treated.
“We are excited to be working with BC Platform’s genomic data management modules,” noted Dr. Wendy A. Wells, Chair of Pathology & Laboratory Medicine at Dartmouth-Hitchcock. “These modules will further enhance our genomic research by providing a vital link to our institutional Bio-Repository.”
Tero Silvola, Chief Executive Officer at BC Platforms, commented: ‘We are delighted to be working in partnership with Dartmouth-Hitchcock to support translational research initiatives in cancer. Together we will explore the use of BC Platforms tertiary analysis tools for individual cancer patients but also explore the function of large batch automated analysis to establish common denominators in disease progression.’
